Asymmetric synthesis plays a critical role in the synthesis of modern pharmaceutical compounds which often contain complex stereochemical information and require a highly controlled synthesis. The Lautens group has developed numerous strategies to assemble heterocycles which often mirror key frameworks found in pharmaceutically important compounds as well as natural products. Chapters 1-4 describe a copper-catalyzed borylative cyclization strategy to access enantioenriched oxindoles, polycyclic indolines, and cyclobutanols. The in-situ generated chiral copper-boron species is proposed to undergo an enantioselective migratory insertion prior to intramolecular cyclization. The newly installed neopentyl boronate was readily converted to new ca...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemistry, 2004.Includes bibliograp...
This thesis describes the combination of non-stabilized nucleophiles and prochiral/racemic electroph...
Heterocycles are prevalent within biologically active molecules, with >70% of FDA approved drugs fea...
Herein is reported an enantio- and diastereoselective tandem double borylation/1,2-addition of alkyn...
Transition metal catalysis has been at the forefront of synthetic organic chemistry as it represents...
The synthesis of heterocycles using transition metal catalysis is a topic of broad interest in the f...
This thesis describes the combination of prochiral/racemic electrophiles and non-stabilised nucleoph...
Watson, Mary P.During the last half century, transition metal-catalyzed cross-coupling reactions hav...
Watson, Mary P.(1) The first project I have worked on is titled Nickel Catalyzed Cyclization of N-Be...
The Dong research group is interested in harnessing the power of transition metal catalysis to trans...
Chiral molecules play a central role in our daily life and in nature, for instance the different ena...
Research in the Stoltz group is directed, generally, at the development of synthetic methods for the...
Chiral molecules play a central role in our daily life and in nature, for instance the different ena...
Research in the Stoltz group is directed, generally, at the development of synthetic methods for the...
Chapter 1 discloses a novel organocatalytic method for the synthesis of pentafulvenes bearing chiral...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemistry, 2004.Includes bibliograp...
This thesis describes the combination of non-stabilized nucleophiles and prochiral/racemic electroph...
Heterocycles are prevalent within biologically active molecules, with >70% of FDA approved drugs fea...
Herein is reported an enantio- and diastereoselective tandem double borylation/1,2-addition of alkyn...
Transition metal catalysis has been at the forefront of synthetic organic chemistry as it represents...
The synthesis of heterocycles using transition metal catalysis is a topic of broad interest in the f...
This thesis describes the combination of prochiral/racemic electrophiles and non-stabilised nucleoph...
Watson, Mary P.During the last half century, transition metal-catalyzed cross-coupling reactions hav...
Watson, Mary P.(1) The first project I have worked on is titled Nickel Catalyzed Cyclization of N-Be...
The Dong research group is interested in harnessing the power of transition metal catalysis to trans...
Chiral molecules play a central role in our daily life and in nature, for instance the different ena...
Research in the Stoltz group is directed, generally, at the development of synthetic methods for the...
Chiral molecules play a central role in our daily life and in nature, for instance the different ena...
Research in the Stoltz group is directed, generally, at the development of synthetic methods for the...
Chapter 1 discloses a novel organocatalytic method for the synthesis of pentafulvenes bearing chiral...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemistry, 2004.Includes bibliograp...
This thesis describes the combination of non-stabilized nucleophiles and prochiral/racemic electroph...
Heterocycles are prevalent within biologically active molecules, with >70% of FDA approved drugs fea...